furin
member
famili
proprotein
convertas
found
mammalian
cell
membraneassoci
calciumdepend
serin
endoproteas
specif
cleav
peptid
bond
pair
basic
amino
acid
residu
substrat
growth
factor
receptor
serum
protein
coagul
factor
extracellular
matrix
protein
ubiquit
express
low
level
within
transgolgi
keyword
furin
kexin
molecular
design
mung
bean
trypsin
inhibitor
peptid
synthesi
correspond
c
chi
highli
activ
smallmolecul
furin
inhibitor
attract
drug
candid
fend
bacteri
exotoxin
viral
infect
base
activ
ly
fragment
mung
bean
trypsin
inhibitor
seri
furin
inhibitor
design
synthes
inhibitori
activ
toward
furin
kexin
evalu
use
enzym
kinet
analysi
potent
inhibitor
contain
amino
acid
residu
k
valu
furin
kexin
design
three
increment
approach
first
two
nonessenti
cy
residu
ly
fragment
delet
via
cystos
mutat
minim
peptid
misfold
second
residu
reactiv
site
inhibitor
replac
consensu
substrat
recognit
sequenc
furin
name
arg
p
ly
p
arg
p
arg
p
addit
p
residu
asp
substitut
ala
avoid
possibl
electrostat
interfer
furin
inhibit
final
extra
ntermin
ctermin
residu
beyond
doubli
conjug
disulfid
loop
truncat
howev
result
synthet
peptid
found
temporari
inhibitor
furin
kexin
prolong
incub
scissil
peptid
bond
p
p
cleav
differ
extent
enzym
enhanc
proteolyt
resist
p
residu
ser
mutat
dser
nmethyls
nmethyls
mutant
gave
rise
k
valu
furin
retain
inhibitori
activ
even
h
incub
enzym
contrast
dser
mutant
resist
cleavag
although
inhibitori
activ
furin
drastic
decreas
find
identifi
use
templat
design
potent
specif
stabl
peptid
inhibitor
furin
shed
light
molecular
determin
dictat
inhibit
furin
kexin
network
endosom
system
furin
also
essenti
activ
bacteri
exotoxin
diphtheria
toxin
anthrax
toxin
process
viral
envelop
glycoprotein
hiv
sar
viru
expect
furin
inhibitor
shown
abl
neutral
bacteri
exotoxin
prevent
viral
infect
therefor
much
recent
work
aim
design
variou
peptidebas
proteinbas
furin
inhibitor
includ
peptidyl
inhibitor
decanoylargvallysargch
cl
bioengin
variant
antitrypsin
portland
pdx
polyarginin
drosophila
serpin
eglin
c
serpinderiv
peptid
barley
serin
proteinas
inhibitor
cyclic
peptid
previou
studi
identifi
mung
bean
trypsin
inhibitor
mbti
compos
amino
acid
residu
seven
disulfid
bond
member
bowmanbirk
proteas
inhibitor
famili
mbti
form
symmetr
structur
consist
two
domain
antitrypsin
reactiv
site
one
locat
ly
domain
arg
domain
activ
ly
arg
domain
separ
limit
peptic
digest
purifi
immobil
trypsin
affin
column
differ
ph
valu
sinc
inhibitori
activ
ly
domain
higher
arg
domain
studi
focus
former
ly
domain
consist
two
peptid
chain
compos
nine
residu
respect
connect
two
interchain
disulfid
bond
synthet
peptid
deriv
long
chain
three
intramolecular
disulfid
bond
remain
activ
trypsin
fig
two
disulfid
isoform
peptid
inhibit
enzym
k
valu
backbonecycl
potent
trypsin
inhibitor
sunflow
trypsin
amino
acid
residu
belong
bowmanbirk
famili
identifi
sunflow
compris
canon
reactiv
site
disulfid
loop
nine
amino
acid
residu
commonli
found
bowmanbirk
famili
inhibitor
disulfid
loop
differ
ly
domain
mbti
one
noncontact
residu
posit
number
ntermin
gli
ile
gln
mbti
fig
c
remain
five
residu
form
backbonecycl
ring
structur
instead
second
disulfid
loop
found
bowmanbirk
inhibitor
surprisingli
sunflow
trypsin
inhibitor
ly
fragment
mbti
adopt
conform
nineresidu
reactiv
site
loop
region
shown
crystal
structur
complex
trypsin
smallmolecul
peptid
inhibitor
proteas
attract
lead
compound
therapeut
develop
potenc
specif
low
toxic
costeffect
one
smallest
peptidebas
natur
trypsin
inhibitor
shown
signific
potenti
use
templat
molecul
design
specif
inhibitor
target
biomed
import
enzym
owe
small
size
strong
inhibitori
activ
trypsin
ly
fragment
mbti
may
also
serv
ideal
templat
design
potent
specif
stabl
furin
inhibitor
report
design
synthesi
variou
peptid
analog
deriv
ly
fragment
mbti
function
character
respect
furin
kexin
optim
ly
fragment
templat
six
cystein
residu
ly
fragment
mbti
fig
pair
form
canon
nineresidu
reactiv
site
loop
indispens
inhibitori
activ
pair
form
second
nineresidu
loop
support
adjac
reactiv
site
loop
import
maintain
stabl
peptid
conform
h
tao
et
al
hand
disulfid
bond
two
correspond
cy
residu
arg
domain
nativ
mbti
appear
nonessenti
structur
function
context
ly
fragment
show
previou
work
oxid
synthet
ly
fragment
result
two
activ
isoform
k
valu
plausibl
canon
disulfid
loop
intact
isoform
isomer
result
multipl
disulfid
connect
afford
therefor
first
step
optim
ly
fragment
templat
replac
ser
order
avoid
unnecessari
disulfid
mispair
result
peptid
two
conjug
nineresidu
loop
term
inde
exhibit
higher
inhibitori
activ
trypsin
k
two
previous
character
disulfid
isoform
ly
fragment
tabl
second
step
introduc
reactiv
site
ly
templat
consensu
substrat
recognit
sequenc
furin
furin
kexin
highli
specif
arg
p
prefer
basic
residu
p
p
contrast
kexin
howev
furin
also
prefer
basic
residu
p
abl
recogn
residu
even
distant
site
stringent
specif
furin
kexin
explain
crystal
structur
electrostat
forc
domin
subsit
interact
enzymeinhibitor
enzymesubstr
complex
appear
specif
determin
construct
alreadi
contain
ly
p
arg
p
thu
meet
minim
requir
furin
kexin
inhibitor
fact
peptid
display
modest
inhibitori
activ
furin
kexin
k
valu
respect
replac
residu
p
p
site
ly
arg
respect
result
k
furin
ie
decreas
two
order
magnitud
compar
accord
previou
find
ly
p
arg
p
combin
prefer
furin
inhibit
substitut
arg
inhibitori
activ
result
furin
increas
fivefold
much
less
extent
kexin
indic
basic
residu
p
site
desir
furin
less
import
kexin
interestingli
replac
ala
inhibitori
activ
result
peptid
furin
kexin
improv
suggest
neg
charg
residu
p
function
deleteri
possibl
due
electrostat
interfer
subsit
interact
involv
neighbor
arg
p
final
step
remov
ntermin
glupros
ctermin
alaasn
residu
flank
truncat
termini
appar
neg
impact
inhibitori
activ
enzym
result
miniatur
residu
potent
furin
inhibitor
k
deriv
ly
fragment
mbti
worth
point
fig
sunflow
trypsin
inhibitor
fig
topolog
structur
contain
activ
canon
nineresidu
loop
conjug
disulfid
loop
backbonecycl
loop
synthet
analog
incub
furin
inhibitori
activ
gradual
decreas
timedepend
fashion
appear
stabl
activ
remain
h
wherea
least
stabl
lost
activ
period
time
similar
result
also
observ
kexin
notabl
higher
k
valu
faster
activ
decay
fig
find
indic
synthet
inhibitor
progress
hydrolyz
probabl
reactiv
site
enzym
prolong
incub
cleav
furin
purifi
sequenc
result
inde
confirm
hydrolysi
p
p
peptid
bond
fig
numer
studi
suggest
conform
rigid
reactiv
site
loop
region
peptid
protein
inhibitor
proteas
key
proteolyt
resist
destabil
reactiv
site
loop
invari
convert
otherwis
strong
inhibitor
good
substrat
enzym
mani
proteas
inhibitor
conform
rigid
reactiv
site
loop
region
partial
provid
sidechainsidechain
interact
p
p
residu
clearli
desalt
sephadex
column
hydrolyz
peptid
use
edman
sequenc
describ
c
incub
trypsin
one
microgram
trypsin
incub
mm
ml
mm
tri
hcl
buffer
ph
contain
mm
cacl
min
twenti
microlit
reaction
mixtur
ad
sequenc
membran
wash
twice
water
remov
salt
fix
cartridg
edman
sequenc
h
tao
et
al
case
ly
fragment
mbti
atom
p
thr
hbond
c
atom
p
ser
fact
thr
consid
optim
residu
p
site
bowmanbirk
inhibitor
thu
surpris
thrtoli
mutat
p
convert
strong
trypsin
inhibitor
k
seri
weak
temporari
one
k
valu
sequenc
analysi
cleavag
product
indic
two
peptid
bond
analog
cleav
incub
trypsin
one
locat
p
p
argci
p
p
argser
fig
highli
plausibl
design
furin
inhibitor
p
ly
absenc
p
p
sidechain
interact
detriment
proteolyt
resist
furin
incorpor
unnatur
amino
acid
peptid
wide
use
design
proteaseresist
peptid
mimet
sinc
damino
acid
recogn
natur
occur
proteas
replac
enzymesuscept
residu
damino
acid
elimin
proteolyt
degrad
exoproteas
endoproteas
mani
option
avail
tackl
proteolysi
chang
peptid
bond
structur
leav
sidechain
untouch
includ
limit
nmethyl
ie
con
ch
peptoid
structur
ie
n
r
ch
co
n
bamino
acid
base
optim
templat
p
residu
ser
mutat
order
construct
stabl
furin
inhibitor
p
ser
replac
dser
nmethyls
result
respect
expect
argdser
peptid
bond
resist
cleavag
howev
inhibitori
activ
furin
due
steric
incomplementar
enzymeinhibitor
complex
drastic
decreas
four
order
magnitud
k
valu
contrast
remain
potent
inhibitor
furin
k
larg
resist
proteolysi
inhibitori
activ
preserv
even
h
incub
furin
fig
worth
point
compar
show
similar
inhibitori
activ
kexin
indic
p
site
residu
critic
interact
enzym
demonstr
seri
increment
modif
ly
fragment
mbti
potent
furin
inhibitor
design
improv
possibl
refin
sequenceact
studi
enhanc
activ
specif
stabil
light
small
size
high
potenc
templat
may
serv
ideal
lead
compound
develop
furin
inhibitorbas
therapeut
treatment
infecti
diseas
design
furin
inhibitor
may
also
provid
use
tool
better
understand
molecular
basi
activ
specif
furin
design
peptid
inhibitor
target
member
proprotein
convertas
famili
well
acm
protect
group
use
remain
two
cystein
residu
peptid
bocamino
acid
activ
equival
amount
n
hobt
coupl
reaction
carri
fourfold
excess
activ
bocamino
acid
first
time
equival
amount
activ
bocamino
acid
next
two
time
final
cycl
peptid
cleav
resin
hf
contain
pcresol
drop
phenol
thioanisol
use
scaveng
remov
free
radic
gener
reaction
min
remov
hf
product
wash
ethyl
acet
extract
trifluoroacet
acid
contain
acetonitril
extract
lyophil
protect
group
except
acm
crude
peptid
remov
hf
cleavag
fmoc
solidphas
synthesi
peptid
perform
abi
peptid
synthes
start
fmocci
trityl
trt
hydroxymethylphenoxymethyl
polystyren
resin
protect
amino
acid
fmocarg
fmocli
boc
fmocdser
tbutyl
tbu
fmocnmethyls
tbu
fmocci
trt
acm
fmochi
trt
fmocglu
trt
trt
protect
group
use
acm
protect
group
use
resin
cleav
trifluoroacet
acid
contain
pcresol
drop
triethylsilan
thioanisol
h
room
temperatur
remov
trifluoroacet
acid
product
wash
diethyl
ether
extract
trifluoroacet
acid
contain
acetonitril
extract
lyophil
obtain
crude
product
acm
group
unremov
select
oxid
disulfid
bond
differ
protect
group
use
cystein
residu
boc
fmoc
solidphas
synthesi
name
hflabil
hfstabl
acm
boc
method
trifluoroacet
acidlabil
trt
trifluoroacet
acidst
acm
fmoc
method
cleavag
hf
boc
method
deprotect
cystein
oxid
form
first
disulfid
bond
canon
loop
acm
protect
group
two
cystein
residu
remov
iodin
oxygen
deprotect
cystein
residu
oxid
form
anoth
disulfid
bond
conjug
loop
fmoc
peptid
synthesi
trt
protect
group
use
first
pair
cystein
residu
conjug
loop
acm
anoth
pair
canon
loop
crude
peptid
mg
synthes
boc
method
fmoc
method
dissolv
ml
urea
contain
amount
dithiothreitol
flush
nitrogen
solut
stopper
tube
incub
h
reduc
peptid
solut
desalt
sephadex
column
amersham
bioscienc
piscataway
nj
usa
wash
trifluoroacet
acid
lyophil
dissolv
ml
trifluoroacet
acid
reduc
peptid
solut
ad
ml
mm
ph
sodium
acet
buffer
mm
methanol
drop
molar
ratio
peptid
peptid
solut
oxid
h
lyophil
desalt
sephadex
column
purifi
hplc
remain
acmprotect
cystein
deprotect
one
milligram
purifi
peptid
ad
ml
acetonitril
contain
trifluoroacet
acid
mm
molar
ratio
peptid
two
disulfid
bond
correctli
pair
peptid
purifi
zorbax
c
column
mm
agil
palo
alto
ca
usa
equilibr
buffer
trifluoroacet
acid
water
flow
rate
mlaemin
peptid
elut
stepwis
gradient
buffer
b
acetonitril
trifluoroacet
acid
min
buffer
b
min
molecular
mass
synthet
peptid
determin
abi
qtrap
mass
spectroscop
consist
theoret
valu
shown
tabl
enzym
activ
furin
kexin
measur
final
volum
ml
hepe
buffer
mm
ph
mm
cacl
triton
mm
bmercaptoethanol
contain
differ
amount
fluorogen
mca
substrat
pyrargthrlysargmca
assay
equival
amount
enzym
ad
releas
nmol
mca
min
enzym
reaction
determin
inhibitori
activ
fix
amount
enzym
first
incub
differ
amount
inhibitor
min
residu
enzym
activ
measur
fluoresc
spectrophotomet
hitachi
tokyo
japan
incub
time
need
equilibrium
reach
enzym
inhibitor
estim
less
min
initi
veloc
min
incub
excit
emiss
wavelength
nm
nm
respect
k
valu
furin
kexin
measur
dixon
plot
v
use
differ
concentr
substrat
lm
furin
lm
kexin
data
three
measur
averag
linear
regress
analysi
standard
error
calcul
use
origin
program
obtain
equilibrium
inhibit
constant
k
inhibitori
activ
synthet
peptid
toward
trypsin
measur
use
substrat
tosylarginin
methyl
ester
tame
one
microgram
trypsin
sigmaaldrich
st
loui
mo
usa
first
incub
min
differ
amount
inhibitor
ml
mm
tri
hcl
ph
buffer
contain
mm
cacl
tame
ad
final
concentr
lm
increas
absorb
immedi
measur
nm
method
describ
use
k
determin
amino
acid
sequenc
perform
autom
edman
degrad
use
perkinelm
appli
biosi
tem
pulsedliquid
phase
protein
sequenc
procis
onlin
pthamino
acid
analyz
